April 30, 2026Journal of the American College of Cardiology
The STS-ACC Transcatheter Valve Therapy National Registry
Why the study?
A comprehensive national resource was needed to monitor the safety and effectiveness of TVT devices, improve patient care, support research, and enhance communication among stakeholders.
Design
National registry
Authors
Discussion
Loading...
Member takes
Implication
Enables national quality benchmarking for TVT care now; leaves open real-world research on device performance and long-term outcomes.
Key Points
- To establish a comprehensive, nationwide clinical data registry tracking the safety, efficacy, and clinical outcomes of emerging transcatheter valve therapies.
- Developed through a multi-stakeholder partnership between the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC).
- Created in collaborative alignment with the Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), and Duke Clinical Research Institute (DCRI).
- Establishes a standardized, objective national platform to monitor postmarket device safety and real-world clinical effectiveness.
- Serves as a centralized analytic and research resource to guide quality improvement in patient care and facilitate interagency communication.
Cite This Study
Carroll et al. (2013) studied this question.